These findings suggest that FTO-mediated cellular senescence, accompanied by mitochondrial dysfunction and apoptosis resistance, are critical molecular mechanisms underlying GDM-induced pathological hypertrophy, and therapeutic targeting of FTO could reverse this cardiac hypertrophic phenotype. This evidence concerns the gene FTO and gestational diabetes.